Table of contents


Top

Editorial

Patently naive p1229

doi:10.1038/nm1109-1229

Intellectual-property protection is a key driver of innovation, and researchers are always keen to file patents to shield their discoveries. Yet scientists often have an uninformed view of the value of their intellectual property. This naiveté slows down translational research.


Top

News

Wireless medical devices advance, weather balloons aside p1231

Jon Evans

doi:10.1038/nm1109-1231


Efforts to improve vaccine stabilization heat up p1232

Meredith Wadman

doi:10.1038/nm1109-1232


Researchers come together to study natural HIV resistance p1233

Cassandra Willyard

doi:10.1038/nm1109-1233


News in brief pp1234 - 1235

doi:10.1038/nm1109-1234


Straight talk with...Joan Scott pp1236 - 1237

Genevive Bjorn

doi:10.1038/nm1109-1236

The Genetics & Public Policy Center (GPPC), located within the Johns Hopkins Berman Institute of Bioethics in Washington, DC, monitors advances in human genetics, including genetic testing, and their translation into clinical medicine. In September 2009, Joan Scott was named the new director of the center. Scott spoke with Genevive Bjorn about the twists and turns of using information from the double helix.


Australian committees set to advise on translational medicine p1238

Simon Grose

doi:10.1038/nm1109-1238a


In debate over AIDS vaccine success, every detail counts p1238

Roxanne Khamsi

doi:10.1038/nm1109-1238b


Patents in Focus

Biomedical patents: Overturning preconceptions p1239

doi:10.1038/nm1109-1239a


Patents in Focus

Sluggish generics entry prompts calls for European patent reform p1239

Lucas Laursen

doi:10.1038/nm1109-1239b


Patents in Focus

Pharma 'patent trolls' remain mostly the stuff of myth p1240

Stu Hutson

doi:10.1038/nm1109-1240a


Patents in Focus

Researchers ponder a patent-free world pp1240 - 1241

Lauren Cahoon

doi:10.1038/nm1109-1240b


Patents in Focus

'Machine or transformation test' put to the test itself p1241

Mike May

doi:10.1038/nm1109-1241


Patents in Focus

Biosimilars legislation awakens data exclusivity debate p1242

Stu Hutson

doi:10.1038/nm1109-1242a


Patents in Focus

Online resource aims to smooth the biomed patent search p1242

Simon Grose

doi:10.1038/nm1109-1242b


Patents in Focus

Pharma positions to survive the impending patent cliff p1243

Mike May

doi:10.1038/nm1109-1243a


Patents in Focus

Prometheus v. Mayo case in the spotlight p1243

Lauren Cahoon

doi:10.1038/nm1109-1243b


Top

Book Review

Rock the cradle p1244

Teresa K Woodruff reviews The Fertility Doctor: John Rock and the Reproductive Revolution by Margaret Marsh & Wanda Ronner

doi:10.1038/nm1109-1244


Top

News and Views

Sepsis: the dark side of histones pp1245 - 1246

Catherine Chaput & Arturo Zychlinsky

doi:10.1038/nm1109-1245

Injection of activated protein C (APC) is the last resort to rescue a patient with severe sepsis. Research into how APC works reveals that the drug inactivates histones (pages 1318–1321), which are toxic during severe sepsis.

See also: Letter by Xu et al.


Autoimmunity: apoptotic fats grease transcription pp1246 - 1248

Keith B Elkon

doi:10.1038/nm1109-1246

Transcription factors known for handling the body's response to lipids promote clearance of apoptotic cells by macrophages, according to new research (pages 1266–1272). When this process goes awry, autoimmunity can result.

See also: Article by Mukundan et al.


Eye vessels saved by rescuing their pericyte partners pp1248 - 1249

David Antonetti

doi:10.1038/nm1109-1248

High blood sugar can lead to diabetic retinopathy and subsequent blindness. Glucose is now found to quench a growth factor that keeps pericytes alive. Without these key support cells, the retinal vasculature degenerates (pages 1298–1306).

See also: Article by Geraldes et al.


Top

Community Corner

Drug may put brakes on Parkinson's disease p1250

doi:10.1038/nm1109-1250


Top

Between Bedside and Bench

Attacking the flu: Neutralizing antibodies may lead to 'universal' vaccine pp1251 - 1252

Grace L Chen & Kanta Subbarao

doi:10.1038/nm1109-1251

Flu remains a major killer because of imperfect vaccines and widespread resistance to existing antivirals—problems particularly acute during a pandemic. New findings at the bedside and at the bench could lead to improvements on both fronts. Grace Chen and Kanta Subbarao discuss the implications of research identifying human antibodies than can neutralize a range of viral subtypes. The findings may help lead to a 'universal' vaccine against these diverse and rapidly evolving viruses. Estanislao Nistal-Villán and Adolfo García-Sastre examine two recent studies that reveal the crystal structure of a promising viral drug target, the unique endonuclease domain of the viral polymerase. The findings open the door to the rational design of new influenza virus inhibitors.


Attacking the flu: New prospects for the rational design of antivirals pp1253 - 1254

Estanislao Nistal-Villán & Adolfo García-Sastre

doi:10.1038/nm1109-1253


Top

Research Highlights

Research Highlights pp1256 - 1257

doi:10.1038/nm1109-1256


Top

Articles

Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines pp1259 - 1265

Ashley L St John & Soman N Abraham

doi:10.1038/nm.2036

Soman Abraham and his colleagues report a new mechanism of immune suppression used by Salmonella. The bacteria traffic to lymph nodes, where Salmonella lipopolysaccharide triggers the downmodulation of certain chemokines, disrupting the cellular organization of the lymph node and impairing adaptive immunity.


PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance pp1266 - 1272

Lata Mukundan, Justin I Odegaard, Christine R Morel, Jose E Heredia, Julia W Mwangi, Roberto R Ricardo-Gonzalez, Y P Sharon Goh, Alex Red Eagle, Shannon E Dunn, Jennifer U H Awakuni, Khoa D Nguyen, Lawrence Steinman, Sara A Michie & Ajay Chawla

doi:10.1038/nm.2048

Macrophages coordinate the disposal of apoptotic cells. Ajay Chawla and his colleagues show that PPAR-delta, a sensor of fatty acids, is involved in this process. Ingestion of apoptotic cells by macrophages prompts the upregulation of PPAR-delta, which then responds by enhancing the expression of opsonins. Lack of PPAR-delta reduces apoptotic cell clearance and predisposes to autoimmunity (pages 1246–1248).

See also: News and Views by Elkon


Dual roles for hepatic lectin receptors in the clearance of chilled platelets pp1273 - 1280

Viktoria Rumjantseva, Prabhjit K Grewal, Hans H Wandall, Emma C Josefsson, Anne Louise Sørensen, Göran Larson, Jamey D Marth, John H Hartwig & Karin M Hoffmeister

doi:10.1038/nm.2030

Unlike other types of blood components, refrigeration of platelets leads to their rapid clearance from the circulation after transfusion. Platelets must therefore be stored at room temperature, a serious limitation to their use for transfusions. Viktoria Rumjantseva et al. now dissect two platelet clearance pathways by which exposed carbohydrate residues on platelets are recognized by receptors on liver macrophages and hepatocytes, which differentially control the clearance of short-term– and long-term–refrigerated platelets.


Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy pp1281 - 1288

David Hassel, Tillman Dahme, Jeanette Erdmann, Benjamin Meder, Andreas Huge, Monika Stoll, Steffen Just, Alexander Hess, Philipp Ehlermann, Dieter Weichenhan, Matthias Grimmler, Henrike Liptau, Roland Hetzer, Vera Regitz-Zagrosek, Christine Fischer, Peter Nürnberg, Heribert Schunkert, Hugo A Katus & Wolfgang Rottbauer

doi:10.1038/nm.2037

David Hassel et al. show that mutations affecting the protein nexilin underlie an unusual type of dilated cardiomyopathy characterized by disrupted Z-disk structures in cardiac muscle. Functional studies in zebrafish revealed that nexilin has an essential role in maintaining Z-disk stability and suggested that the disease-causing nexilin mutations found in humans encode proteins that act in a dominant-negative fashion.


Notch3 signaling promotes the development of pulmonary arterial hypertension pp1289 - 1297

Xiaodong Li, Xiaoxue Zhang, Robin Leathers, Ayako Makino, Chengqun Huang, Pouria Parsa, Jesus Macias, Jason X-J Yuan, Stuart W Jamieson & Patricia A Thistlethwaite

doi:10.1038/nm.2021

Notch signaling is known to modulate the phenotype of vascular smooth muscle cells. Xiaodong Li et al. now provide evidence for the importance of signaling through the NOTCH3 receptor and its downstream target HES-5 in pulmonary arterial smooth muscle cells for the development of pulmonary arterial hypertension, and they demonstrate the therapeutic potential of targeting this signaling pathway in a mouse model of pulmonary hypertension.


Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy pp1298 - 1306

Pedro Geraldes, Junko Hiraoka-Yamamoto, Motonobu Matsumoto, Allen Clermont, Michael Leitges, Andre Marette, Lloyd P Aiello, Timothy S Kern & George L King

doi:10.1038/nm.2052

Vascular defects resulting from pericyte cell death are thought to be a major underlying cause of diabetic retinopathy. Pedro Geraldes et al. investigate the signaling mechanisms by which hyperglycemia leads to pericyte death and delineate a pathway by which PKC-delta activation decreases antiapoptotic PDGF receptor signaling (pages 1248–1249).

See also: News and Views by Antonetti


Top

Letters

Foxo1 integrates insulin signaling with mitochondrial function in the liver pp1307 - 1311

Zhiyong Cheng, Shaodong Guo, Kyle Copps, Xiaochen Dong, Ramya Kollipara, Joseph T Rodgers, Ronald A Depinho, Pere Puigserver & Morris F White

doi:10.1038/nm.2049

Hepatic insulin resistance is often associated with mitochondrial dysfunction, leading to defects in cellular activity. Morris White and his colleagues have now found that continued activity of the transcription factor Foxo1, which is normally inhibited by insulin signaling, is at the crux of this dysfunction, and, when it is genetically deleted, proper mitochondrial function in two models of insulin resistance is restored.


Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency pp1312 - 1317

Yu Liang, Jodi L Vogel, Aarthi Narayanan, Hua Peng & Thomas M Kristie

doi:10.1038/nm.2051

Viral gene expression can be regulated by chromatin methylation and demethylation. Thomas Kristie and his colleagues have identified a histone demethylase that is required to remove repressive methylation from the immediate early promoters of two alpha-herpesviruses. Monoamine oxidase inhibitors, which block this demethylase, prevented lytic replication and reactivation from latency.


Extracellular histones are major mediators of death in sepsis pp1318 - 1321

Jun Xu, Xiaomei Zhang, Rosana Pelayo, Marc Monestier, Concetta T Ammollo, Fabrizio Semeraro, Fletcher B Taylor, Naomi L Esmon, Florea Lupu & Charles T Esmon

doi:10.1038/nm.2053

Extracellular histones released in response to inflammatory challenge contribute to organ failure and death during sepsis. Histone-specific antibodies and activated protein C had beneficial effects in animal models of sepsis, pointing to extracellular histones as therapeutics targets for sepsis and other inflammatory conditions (pages 1245–1246).

See also: News and Views by Chaput & Zychlinsky


Top

Technical Reports

Major histocompatibility complex genotyping with massively parallel pyrosequencing pp1322 - 1326

Roger W Wiseman, Julie A Karl, Benjamin N Bimber, Claire E O'Leary, Simon M Lank, Jennifer J Tuscher, Ann M Detmer, Pascal Bouffard, Natalya Levenkova, Cynthia L Turcotte, Edward Szekeres Jr, Chris Wright, Timothy Harkins & David H O'Connor

doi:10.1038/nm.2038

Nonhuman primates are key preclinical models for infectious disease, vaccine development and transplantation research, but their use has been hampered by the complexity and diversity of their major histocompatibility complex (MHC) class I genotypes. Wiseman and his colleagues provide a cost-effective solution to this problem using a next-generation pyrosequencing approach to high-resolution MHC genotyping in various nonhuman primates, identifying both known and new MHC class I alleles.


Matrix-insensitive protein assays push the limits of biosensors in medicine pp1327 - 1332

Richard S Gaster, Drew A Hall, Carsten H Nielsen, Sebastian J Osterfeld, Heng Yu, Kathleen E Mach, Robert J Wilson, Boris Murmann, Joseph C Liao, Sanjiv S Gambhir & Shan X Wang

doi:10.1038/nm.2032

Despite progress in the biosensor field, a platform that allows the sensitive detection of disease-specific proteins in a diverse range of clinical samples such as saliva, serum and urine has proved elusive. Here, Richard Gaster and his colleagues introduce a magnetic nanosensing protein detection platform that offers quantitative multiplex protein detection at attomolar concentrations over a large linear dynamic range and in a range of biological fluids.


Top

Erratum

Erratum: A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis p1333

Tony Muchamuel, Michael Basler, Monette A Aujay, Erika Suzuki, Khalid W Kalim, Christoph Lauer, Catherine Sylvain, Eileen R Ring, Jamie Shields, Jing Jiang, Peter Shwonek, Francesco Parlati, Susan D Demo, Mark K Bennett, Christopher J Kirk & Marcus Groettrup

doi:10.1038/nm1109-1333a


Top

Corrigendum

Corrigendum: Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells p1333

Natalie A Hutnick, Diane G Carnathan, Sheri A Dubey, George Makedonas, Kara S Cox, Lisa Kierstead, Sarah J Ratcliffe, Michael N Robertson, Danilo R Casimiro, Hildegund C J Ertl & Michael R Betts

doi:10.1038/nm1109-1333b


Top

Extra navigation

Subscribe to Nature Medicine

Subscribe

naturejobs

ADVERTISEMENT